Clinical Study

Awareness And Utilization Of Preventative ‘Top’ And ‘Bottom’ Cancer Screenings Among Trans Male/Masculine Persons And Those Assigned Female At Birth (Afab): A Mixed-Methods Study

Posted Date: Jul 13, 2021

  • Investigator: Rachael Nolan
  • Specialties: Breast Cancer, Cancer, Gynecologic Oncology, Ovarian Cancer
  • Type of Study: Observational/Survey

In order to design inclusive and effective risk mitigation and cancer prevention initiatives for trans male/masculine/AFAB persons, it is important to more thoroughly understand top and bottom cancer risk awareness, as well as the utilization of cancer preventative screenings for both top and bottom cancers. The current study will use an adapted version of the Cancer Awareness Measure (CAM), an established validated and reliable instrument that has not yet been used with a trans male/masculine/AFAB population. This research will provide critical information in the aforementioned areas of interest by filling in the gap of previous literature that has lacked insight into the real lived experiences of trans male/masculine/AFAB persons, as well as their knowledge of cancer risk, and will offer greater clinical understanding on the health behaviors of this unique population towards the prevention of cancer.


Individuals Who Are: 1) = 18 Years Of Age; 2) Self-Identify As Trans Male/Masculine/Afab Persons; And 3) Are Able To Read, Write, And Speak English; And 4) Reside In The U.S. And Its Territories.


Transgender, Cancer, Non-Binary

For More Information:

Dr. Rachael D. Nolan

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.